Altogether, these results suggest that the LRP4/YAP axis is one of the key regulators of iCSC reprogramming and that LRP4 depletion may be a therapeutic opportunity to sensitize breast cancer cells to irradiation. This evidence concerns the gene YAP1 and breast carcinoma.